Clinical trial using blood-plasma transfusions shows promise for Alzheimer’s disease

Massive amounts of money and effort are being put into researching treatments and ultimately a cure for Alzheimer's disease. A clinical trial has been running that is using human blood-plasma transfusions to treat the disease has found that the treatments are safe and promising for those suffering from the disease. Stanford University School of Medicine investigators have reported success with this treatment in an early-phase clinical trial.